Results 111 to 120 of about 8,720 (195)

Cilostazol-Induced Digoxin Toxicity Presenting as Accelerated Idioventricular Rhythm and Recurrent Syncope. [PDF]

JACC Case Rep
Madanieh S, Desai D, Goedert GM, Shultz J, Hussain H.   +4 more
europepmc   +1 more source

Adjunctive Cilostazol Therapy for Sinus Node Dysfunction After Heart Transplantation. [PDF]

JACC Case Rep
Tamano K, Takenaka S, Nagai T, Anzai T.
europepmc   +1 more source

Cilostazol use and calf muscle pathophysiology in people with peripheral artery disease. [PDF]

Vasc Med
Choi J, Kim K, Thome T, Stone L, Vugman N, Pass CG, Palzkill VR, Yang Q, Anderson EM, Fazzone B, Berceli SA, Scali ST, Ryan TE.   +12 more
europepmc   +1 more source

Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis. [PDF]

J Am Heart Assoc
Hiruma Y, Watanabe A, Aikawa T, Iwagami M, Slipczuk L, Wiley J, Briasoulis A, Secemsky E, Laham R, Kuno T.   +9 more
europepmc   +1 more source

Cilostazol mitigates amiodarone-induced pulmonary toxicity and fibrosis by regulating the cAMP/TGF-β1 pathway-mediated epithelial-to-mesenchymal transition in rats. [PDF]

Sci Rep
El-Gammal MA, Yousef EH, Abd Elhameed AG, Salama MM, Salahuddin MM.   +4 more
europepmc   +1 more source

Temporary Interruption versus Continuation of Non-aspirin, Non-P2Y12 Antiplatelet Monotherapy for Delayed Post-polypectomy Bleeding. [PDF]

Endosc Int Open
Okagawa Y, Sato M, Hirakawa M, Seto K, Ito R, Oomori G, Saeki S, Oiwa S, Hayasaka N, Miura S, Abe T, Minami S, Sumiyoshi T, Nagaoka Y, Hisai H, Katsuki S, Ohnishi H, Takada K.   +17 more
europepmc   +1 more source

Effects of cilostazol on renal function, renal blood flow, and long-term prognosis in patients with chronic kidney disease. [PDF]

Clin Exp Nephrol
Saito C, Mase K, Ishibashi S, Harada T, Tsunoda R, Usui T, Simizu T, Nagai K, Ohkubo R, Morito N, Hagiwara M, Kai H, Usui J, Yamagata K.   +13 more
europepmc   +1 more source

Managing Antithrombotic Treatment in Intracerebral Hemorrhage and Ischemic Stroke Due to Cerebral Amyloid Angiopathy With Supporting Pathology. [PDF]

Cureus
Nobleza CMN, Bustamante CMP, Sih IMY, Rosales RL.   +3 more
europepmc   +1 more source

The role of cilostazol in the treatment of intermittent claudication

This paper represents a review, by experts, of current opinion and information on intermittent claudication (IC) and the role that cilostazol plays in its treatment.
Crichton B, Mikhailidis DP, Homer-Vanniasinkam S, Donnelly R, Bradbury AW, Brittenden J, Barnett AH, Stansby G   +7 more
core  

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease. [PDF]

Ann Med
Lin CW, Huang YY, Lin CH, Huang CH, Hung SY, Chen IW, Chen YC, Liu PH.   +7 more
europepmc   +1 more source